Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001104659-26-076967 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
5,368,128
Total Value
$399,658,667.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 23, 2026 | Conversion | 666,680 | โ | โ | 4,684,781 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details | |
Director | Common Stock | โ | Jun 23, 2026 | Sale | 4,684,781 | $85.31 | $399,658,667.11 | 0 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details | |
Director | Series B Preferred Stock | Derivative | Jun 23, 2026 | Conversion | 16,667 | $0.00 | $0.00 | 0 | Indirect | Fairmount Healthcare Fund II LP | View Details |